NPI: 1336103043 · CARSON CITY, MI 48811 · General Acute Care Hospital · NPI assigned 04/12/2006
Authorized official RUSSIAN, MISTY controls 20+ related entities in our dataset. Read more
| Authorized Official | RUSSIAN, MISTY (SUPERVISOR, PROVIDER ENROLLMENT) |
| Parent Organization | SPARROW HEALTH SYSTEM |
| NPI Enumeration Date | 04/12/2006 |
Other providers sharing the same authorized official: RUSSIAN, MISTY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 14,616 | $672K |
| 2019 | 18,833 | $603K |
| 2020 | 17,474 | $582K |
| 2021 | 25,986 | $911K |
| 2022 | 28,569 | $1.01M |
| 2023 | 26,457 | $952K |
| 2024 | 20,112 | $744K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4,071 | 3,818 | $1.27M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 9,122 | 8,713 | $1.12M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 4,670 | 4,485 | $881K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3,445 | 3,189 | $340K |
| 62323 | 975 | 956 | $289K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2,352 | 2,296 | $167K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2,715 | 2,630 | $125K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2,083 | 2,025 | $122K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 741 | 723 | $107K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2,862 | 2,565 | $94K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 856 | 778 | $85K |
| 64493 | 154 | 150 | $66K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 1,983 | 1,796 | $54K |
| 71045 | Radiologic examination, chest; single view | 1,242 | 1,202 | $52K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2,254 | 646 | $50K |
| 71046 | Radiologic examination, chest; 2 views | 1,250 | 1,207 | $43K |
| 80061 | Lipid panel | 4,594 | 4,587 | $39K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 811 | 811 | $39K |
| 70450 | Computed tomography, head or brain; without contrast material | 430 | 420 | $38K |
| 84443 | Thyroid stimulating hormone (TSH) | 5,350 | 5,303 | $34K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2,416 | 2,396 | $34K |
| 80053 | Comprehensive metabolic panel | 13,638 | 12,696 | $34K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2,187 | 2,170 | $30K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,081 | 1,053 | $28K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 366 | 362 | $28K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 256 | 246 | $26K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 1,404 | 1,400 | $19K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 1,799 | 1,795 | $19K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 11,455 | 10,380 | $19K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1,370 | 1,355 | $19K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4,107 | 4,098 | $15K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1,219 | 1,152 | $15K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 223 | 222 | $12K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 50 | 50 | $11K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,079 | 1,077 | $11K |
| 76830 | Ultrasound, transvaginal | 177 | 175 | $10K |
| 84439 | 2,131 | 2,123 | $9K | |
| M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | 28 | 28 | $8K |
| 82607 | 1,138 | 1,134 | $6K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 3,031 | 2,888 | $5K |
| 73610 | 272 | 254 | $5K | |
| 20610 | 51 | 50 | $5K | |
| 73630 | 368 | 351 | $4K | |
| 86803 | 600 | 598 | $4K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2,224 | 2,053 | $4K |
| 82728 | 612 | 602 | $4K | |
| 97161 | 66 | 66 | $3K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 437 | 427 | $3K |
| 36415 | Collection of venous blood by venipuncture | 2,336 | 2,123 | $3K |
| 85027 | 2,216 | 2,033 | $3K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 24 | 24 | $3K |
| 87077 | 1,162 | 1,095 | $3K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 245 | 245 | $3K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1,208 | 1,116 | $3K |
| 83550 | 688 | 682 | $3K | |
| 87210 | 1,110 | 1,089 | $2K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 24 | 24 | $2K |
| 83540 | 814 | 807 | $2K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 39 | 39 | $2K |
| 82652 | 149 | 148 | $2K | |
| 73130 | 121 | 106 | $2K | |
| 81514 | 13 | 13 | $2K | |
| 82043 | 1,013 | 1,013 | $2K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 161 | 161 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 626 | 530 | $2K |
| 87186 | 778 | 743 | $2K | |
| 82570 | 980 | 975 | $2K | |
| 73562 | 111 | 111 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2,009 | 1,840 | $2K |
| 87625 | 79 | 73 | $1K | |
| 83721 | 386 | 386 | $1K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 25 | 25 | $1K |
| 73030 | 55 | 53 | $1K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 12 | 12 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,442 | 1,397 | $1K |
| 84703 | 2,585 | 2,490 | $885.25 | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 14 | 14 | $815.68 |
| 86140 | 1,403 | 1,331 | $770.87 | |
| 85610 | 1,422 | 1,255 | $725.47 | |
| 76801 | 13 | 13 | $699.12 | |
| 0002A | 20 | 20 | $690.28 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 93 | 93 | $654.95 |
| 83735 | 1,558 | 1,459 | $650.58 | |
| 86900 | 14 | 14 | $463.97 | |
| 74018 | 24 | 24 | $429.60 | |
| 87070 | 136 | 129 | $410.53 | |
| 83690 | 1,732 | 1,622 | $395.52 | |
| 0001A | 17 | 17 | $336.85 | |
| 81001 | 3,322 | 3,153 | $333.63 | |
| 87420 | 439 | 427 | $306.59 | |
| 83880 | 291 | 278 | $238.38 | |
| 85730 | 798 | 771 | $236.75 | |
| 87510 | 42 | 40 | $226.29 | |
| 87480 | 42 | 40 | $226.29 | |
| 84478 | 97 | 97 | $202.53 | |
| 86780 | 25 | 25 | $181.61 | |
| 84702 | 31 | 24 | $129.71 | |
| 85652 | 148 | 142 | $109.67 | |
| 83516 | 12 | 12 | $89.46 | |
| 85007 | 134 | 121 | $87.88 | |
| 81003 | 1,330 | 1,280 | $84.68 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 82 | 81 | $81.97 |
| 87660 | 13 | 13 | $63.01 | |
| 84484 | 1,473 | 1,350 | $33.14 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,139 | 1,125 | $32.30 |
| 82947 | 18 | 18 | $25.50 | |
| 86038 | 13 | 13 | $21.61 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,854 | 1,804 | $12.00 |
| 85379 | 13 | 13 | $7.77 | |
| 83605 | 406 | 362 | $7.62 | |
| 99152 | 2,015 | 1,987 | $7.13 | |
| Q0245 | Injection, bamlanivimab and etesevimab, 2100 mg | 28 | 28 | $6.13 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 162 | 162 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1,530 | 1,414 | $0.00 |
| 64494 | 107 | 106 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 55 | 51 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 96 | 91 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 454 | 437 | $0.00 |
| 96376 | 103 | 81 | $0.00 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 360 | 352 | $0.00 |
| 87040 | 12 | 12 | $0.00 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 169 | 165 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 14 | 13 | $0.00 |
| 82962 | 86 | 63 | $0.00 | |
| 86901 | 14 | 14 | $0.00 | |
| 86850 | 14 | 14 | $0.00 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 1,177 | 1,157 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 920 | 847 | $0.00 |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 77 | 77 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 318 | 272 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 12 | 12 | $0.00 |